- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ad26.RSV.FA2
Total 103 results
-
Crucell Holland BVCompleted
-
Crucell Holland BVCompletedRespiratory Tract Infections | Respiratory Syncytial VirusesUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
Janssen Vaccines & Prevention B.V.National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Mahidol UniversityJanssen Pharmaceuticals; International Vaccine Institute; National Vaccine Institute...RecruitingSARS-CoV-2 InfectionThailand
-
Janssen Vaccines & Prevention B.V.CompletedCoronavirus Disease-2019 (COVID-19) PreventionSouth Africa, Brazil, Argentina, Mexico, India
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Tract Infections | Respiratory Syncytial VirusesUnited Kingdom, Finland, United States
-
Janssen Vaccines & Prevention B.V.Bavarian NordicTerminatedHuman Papillomavirus InfectionsUnited States, Belgium
-
Janssen Vaccines & Prevention B.V.CompletedA Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy AdultsCOVID-19 PreventionUnited States, Germany, Brazil, Poland, South Africa
-
Universiteit AntwerpenJohnson & Johnson; University of Kinshasa; Innovative Medicines Initiative; Coalition... and other collaboratorsCompletedEbola Virus DiseaseCongo, The Democratic Republic of the
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus PreventionUnited States
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus PreventionUnited States
-
Janssen Vaccines & Prevention B.V.Completed
-
Crucell Holland BVCompleted
-
University of OxfordCompleted
-
Janssen Vaccines & Prevention B.V.CompletedCOVID-19 PreventionUnited States, South Africa, Brazil
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial Virus Infection PreventionGermany, Spain, Belgium, Sweden, United States
-
MRC/UVRI and LSHTM Uganda Research UnitEpicentre, Paris, France.; Janssen Pharmaceutica N.V., Belgium; Coalition for... and other collaboratorsCompleted
-
Janssen Research & Development, LLCNo longer available
-
Janssen Pharmaceutical K.K.Terminated
-
South China Center For Innovative PharmaceuticalsXiangya Hospital of Central South UniversityCompleted
-
University Medical Center GroningenRadboud University Medical Center; Erasmus Medical Center; Academisch Medisch... and other collaboratorsCompletedKidney Diseases | Covid19 | SARS-CoV2 Infection | Vaccine Response ImpairedNetherlands
-
Ministerio de Salud de Ciudad Autónoma de Buenos...Active, not recruitingCOVID-19 VaccinesArgentina
-
Centre Hospitalier Universitaire de Saint EtienneActive, not recruiting
-
Janssen Vaccines & Prevention B.V.CompletedHuman Immunodeficiency VirusThailand
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited Kingdom, Germany, Spain, Netherlands
-
Janssen Vaccines & Prevention B.V.Completed
-
South China Center For Innovative PharmaceuticalsXiangya Hospital of Central South UniversityCompleted
-
Janssen Vaccines & Prevention B.V.CompletedRespiratory Syncytial VirusCanada, United Kingdom, Spain, Brazil, Sweden, Poland, Australia, Finland
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Janssen Vaccines & Prevention B.V.Terminated
-
London School of Hygiene and Tropical MedicineCompletedHiv | Ebola Virus Disease | EbolaKenya, Uganda
-
Janssen Vaccines & Prevention B.V.Completed
-
Alvea Holdings, LLCCompletedSars-CoV-2 InfectionSouth Africa
-
Janssen Vaccines & Prevention B.V.CompletedCOVID-19 PreventionUnited States, Belgium, Poland
-
London School of Hygiene and Tropical MedicinePublic Health England; Janssen Vaccines & Prevention B.V.; Epicentre; Coalition... and other collaboratorsActive, not recruitingEbola Virus DiseaseCongo, The Democratic Republic of the
-
Janssen Vaccines & Prevention B.V.Institut National de la Santé Et de la Recherche Médicale, France; University...CompletedEbola Viral DiseaseFrance, United Kingdom
-
Janssen Vaccines & Prevention B.V.Emory University; Coalition for Epidemic Preparedness Innovations; Center for...Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Crucell Holland BVCompleted